(S)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-017174-20-AT (EUCTR)	09/02/2011	07/12/2010	A trial to determine if safinamide can attenuate levodopa induced dyskinesia in Parkinson’s disease. ...	A double-blind, randomized, placebo-controlled, parallel-group, dose escalation trial to explore the ...	Idiopathic Parkinson's disease MedDRA version: 14.0;Level: PT;Classification code 10061536;Term: Par ...	Product Name: Safinamide Product Code: NW-1015E, EMD 1195686, MSC2191632B INN or Proposed INN: safinam ...	Merck Serono S.A. - Geneva	NULL	Not Recruiting			Female: yes Male: yes	24		Germany;Canada;France;Austria;South Africa
2	EUCTR2009-017174-20-DE (EUCTR)	15/03/2010	07/01/2010	A trial to determine if safinamide can attenuate levodopa induced dyskinesia in Parkinson’s disease. ...	A double-blind, randomized, placebo-controlled, parallel-group, dose escalation trial to explore the ...	Idiopathic Parkinson's disease MedDRA version: 14.0;Level: PT;Classification code 10061536;Term: Par ...	Product Name: Safinamide Product Code: NW-1015E, EMD 1195686, MSC2191632B INN or Proposed INN: safinam ...	Merck Serono S.A. - Geneva	NULL	Not Recruiting			Female: yes Male: yes	24		France;Canada;Austria;South Africa;Germany

First Previous1Next Last